Persyn Diederik, Malenstein Hannah Van, Vanderschueren Emma, Schuermans Annette, Dreesen Mira, Meert Wouter, Buysschaert Kristof, Merwe Schalk Van Der, Laleman Wim
Department of Gastroenterology and Hepatology, Section of Liver and Biliopancreatic Disorders, University Hospitals Leuven, Belgium (Diederik Persyn, Hannah Van Malenstein, Emma Vanderschueren, Kristof Buysschaert, Schalk Van Der Merwe, Wim Laleman).
Department of Gastroenterology and Hepatology, AZ Damiaan, Ostend, Belgium (Diederik Persyn).
Ann Gastroenterol. 2022 Jul-Aug;35(4):368-375. doi: 10.20524/aog.2022.0723. Epub 2022 Jun 2.
Despite the standardization and optimization of disinfection protocols, duodenoscope-related infections (DRIs) remain an emerging threat for patients undergoing endoscopic retrograde cholangiopancreatography (ERCP). Single-use duodenoscopes could represent a potential alternative avenue to circumvent the problem of reprocessing and thus risk of exogenous patient-to-patient transmission. The aim of our study was to test the feasibility and technical success rate of a recently made available single-use duodenoscope.
We carried out a thorough and standardized evaluation of the usability, performance and safety of a recently developed single-use duodenoscope in 52 consecutive patients scheduled for ERCP in a single center. Outcomes included performance ratings of the single-use duodenoscopes, adverse events (assessed at 3 days and 1 week), and crossover rate to a reusable duodenoscope.
The ERCP completion rate with a single-use duodenoscope was 90.4%, rising to 94.2% after crossover to reusable duodenoscope. The mean American Society for Gastrointestinal Endoscopy (ASGE) grade was 2.7, with 27 procedures (51.9%) considered as advanced level complexity (ASGE grade 3 & 4). Performance rating found that 94% of the therapeutic treatments were comparable to those using a traditional reusable duodenoscope. Overall satisfaction amounted to 80%. No major adverse events were attributable to the single-use endoscope.
Single-use duodenoscopes can provide an alternative to avoid the intensive and often inconsistent results of cleaning and disinfection procedures. We confirmed the feasibility, adequate performance characteristics and safety of a recently developed first-generation single-use duodenoscope over a broad range of ERCP procedures, in terms of both indication and complexity.
尽管消毒方案已实现标准化和优化,但十二指肠镜相关感染(DRIs)仍然是接受内镜逆行胰胆管造影术(ERCP)患者面临的新威胁。一次性使用十二指肠镜可能是解决再处理问题以及由此导致的患者间外源性传播风险的潜在替代途径。我们研究的目的是测试一种最近可用的一次性使用十二指肠镜的可行性和技术成功率。
我们在一个中心对52例计划接受ERCP的连续患者中,对一种最近开发的一次性使用十二指肠镜的可用性、性能和安全性进行了全面且标准化的评估。结果包括一次性使用十二指肠镜的性能评级、不良事件(在3天和1周时评估)以及改用可重复使用十二指肠镜的转换率。
一次性使用十二指肠镜的ERCP完成率为90.4%,改用可重复使用十二指肠镜后升至94.2%。美国胃肠内镜学会(ASGE)平均分级为2.7级,27例操作(51.9%)被认为是高级别复杂程度(ASGE 3级和4级)。性能评级发现,94%的治疗操作与使用传统可重复使用十二指肠镜的操作相当。总体满意度达80%。没有重大不良事件可归因于一次性使用内镜。
一次性使用十二指肠镜可提供一种替代方案,以避免清洁和消毒程序繁琐且往往不一致的结果。我们证实了一种最近开发的第一代一次性使用十二指肠镜在广泛的ERCP操作中,在适应证和复杂程度方面均具有可行性、足够的性能特征和安全性。